Literature DB >> 28724766

A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.

Yuko Ishihara1, Yukie Tanaka1,2, Seiichiro Kobayashi2, Koji Kawamura1, Hideki Nakasone1, Ayumi Gomyo1, Jin Hayakawa1, Masaharu Tamaki1, Yu Akahoshi1, Naonori Harada1, Machiko Kusuda1, Kazuaki Kameda1, Tomotaka Ugai1, Hidenori Wada1, Kana Sakamoto1, Miki Sato1, Kiriko Terasako-Saito1, Misato Kikuchi1, Shun-Ichi Kimura1, Aki Tanihara1, Shinichi Kako1, Kaoru Uchimaru3, Yoshinobu Kanda4.   

Abstract

We previously reported that the T-cell receptor (TCR) repertoire of human T-cell lymphotropic virus type 1 (HTLV-1) Tax301-309-specific CD8+ cytotoxic T cells (Tax301-309-CTLs) was highly restricted and a particular amino acid sequence motif, the PDR motif, was conserved among HLA-A*24:02-positive (HLA-A*24:02+) adult T-cell leukemia/lymphoma (ATL) patients who had undergone allogeneic hematopoietic cell transplantation (allo-HSCT). Furthermore, we found that donor-derived PDR+ CTLs selectively expanded in ATL long-term HSCT survivors with strong CTL activity against HTLV-1. On the other hand, the TCR repertoires in Tax301-309-CTLs of asymptomatic HTLV-1 carriers (ACs) remain unclear. In this study, we directly identified the DNA sequence of complementarity-determining region 3 (CDR3) of the TCR-β chain of Tax301-309-CTLs at the single-cell level and compared not only the TCR repertoires but also the frequencies and phenotypes of Tax301-309-CTLs between ACs and ATL patients. We did not observe any essential difference in the frequencies of Tax301-309-CTLs between ACs and ATL patients. In the single-cell TCR repertoire analysis of Tax301-309-CTLs, 1,458 Tax301-309-CTLs and 140 clones were identified in this cohort. Tax301-309-CTLs showed highly restricted TCR repertoires with a strongly biased usage of BV7, and PDR, the unique motif in TCR-β CDR3, was exclusively observed in all ACs and ATL patients. However, there was no correlation between PDR+ CTL frequencies and HTLV-1 proviral load (PVL). In conclusion, we have identified, for the first time, a unique amino acid sequence, PDR, as a public TCR-CDR3 motif against Tax in HLA-A*24:02+ HTLV-1-infected individuals. Further investigations are warranted to elucidate the role of the PDR+ CTL response in the progression from carrier state to ATL.IMPORTANCE ATL is an aggressive T-cell malignancy caused by HTLV-1 infection. The HTLV-1 regulatory protein Tax aggressively promotes the proliferation of HTLV-1-infected lymphocytes and is also a major target antigen for CD8+ CTLs. In our previous evaluation of Tax301-309-CTLs, we found that a unique amino acid sequence motif, PDR, in CDR3 of the TCR-β chain of Tax301-309-CTLs was conserved among ATL patients after allo-HSCT. Furthermore, the PDR+ Tax301-309-CTL clones selectively expanded and showed strong cytotoxic activities against HTLV-1. On the other hand, it remains unclear how Tax301-309-CTL repertoire exists in ACs. In this study, we comprehensively compared Tax-specific TCR repertoires at the single-cell level between ACs and ATL patients. Tax301-309-CTLs showed highly restricted TCR repertoires with a strongly biased usage of BV7, and PDR, the unique motif in TCR-β CDR3, was conserved in all ACs and ATL patients, regardless of clinical subtype in HTLV-1 infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  HTLV-1 Tax; T-cell receptor; cytotoxic T cells; single-cell repertoire analysis

Mesh:

Substances:

Year:  2017        PMID: 28724766      PMCID: PMC5599769          DOI: 10.1128/JVI.00974-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.

Authors:  Annetie Oxenius; Andrew K Sewell; Sara J Dawson; Huldrych F Günthard; Marek Fischer; Geraldine M Gillespie; Sarah L Rowland-Jones; Catherine Fagard; Bernard Hirschel; Rodney E Phillips; David A Price
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

2.  Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.

Authors:  Yukie Tanaka; Hideki Nakasone; Rie Yamazaki; Ken Sato; Miki Sato; Kiriko Terasako; Shun-ichi Kimura; Shinya Okuda; Shinichi Kako; Kumi Oshima; Aki Tanihara; Junji Nishida; Toshiaki Yoshikawa; Tetsuya Nakatsura; Haruo Sugiyama; Yoshinobu Kanda
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

Review 3.  CD57+ T lymphocytes and functional immune deficiency.

Authors:  Daniele Focosi; Marco Bestagno; Oscar Burrone; Mario Petrini
Journal:  J Leukoc Biol       Date:  2009-10-30       Impact factor: 4.962

4.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.

Authors:  Masako Iwanaga; Toshiki Watanabe; Atae Utsunomiya; Akihiko Okayama; Kaoru Uchimaru; Ki-Ryang Koh; Masao Ogata; Hiroshi Kikuchi; Yasuko Sagara; Kimiharu Uozumi; Manabu Mochizuki; Kunihiro Tsukasaki; Yoshio Saburi; Masaomi Yamamura; Junji Tanaka; Yukiyoshi Moriuchi; Shigeo Hino; Shimeru Kamihira; Kazunari Yamaguchi
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

5.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

Review 6.  T-cell repertoire diversity and clonal expansions in normal and clinical samples.

Authors:  C Pannetier; J Even; P Kourilsky
Journal:  Immunol Today       Date:  1995-04

Review 7.  Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.

Authors:  Kenji Ishitsuka; Kazuo Tamura
Journal:  Lancet Oncol       Date:  2014-10       Impact factor: 41.316

8.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

9.  Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.

Authors:  Geraldine M A Gillespie; Guillaume Stewart-Jones; Jaya Rengasamy; Tara Beattie; Job J Bwayo; Francis A Plummer; Rupert Kaul; Andrew J McMichael; Philippa Easterbrook; Tao Dong; E Yvonne Jones; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

10.  HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor.

Authors:  Tao Dong; Guillaume Stewart-Jones; Nan Chen; Philippa Easterbrook; Xiaoning Xu; Laura Papagno; Victor Appay; Michael Weekes; Chris Conlon; Celsa Spina; Susan Little; Gavin Screaton; Anton van der Merwe; Douglas D Richman; Andrew J McMichael; E Yvonne Jones; Sarah L Rowland-Jones
Journal:  J Exp Med       Date:  2004-12-13       Impact factor: 14.307

View more
  4 in total

1.  T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma.

Authors:  Xuefeng Wang; Jameel Muzaffar; Kedar Kirtane; Feifei Song; Matthew Johnson; Michael J Schell; Jiannong Li; Sean J Yoder; Jose R Conejo-Garcia; Jose A Guevara-Patino; Marcelo Bonomi; Priyanka Bhateja; James W Rocco; Conor E Steuer; Nabil F Saba; Christine H Chung
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

2.  Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation.

Authors:  Hideki Nakasone; Machiko Kusuda; Kiriko Terasako-Saito; Koji Kawamura; Yu Akahoshi; Masakatsu Kawamura; Junko Takeshita; Shunto Kawamura; Nozomu Yoshino; Kazuki Yoshimura; Yukiko Misaki; Ayumi Gomyo; Kazuaki Kameda; Masaharu Tamaki; Aki Tanihara; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Commun Biol       Date:  2021-10-11

3.  Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.

Authors:  Yukie Tanaka; Tomoo Sato; Naoko Yagishita; Junji Yamauchi; Natsumi Araya; Satoko Aratani; Katsunori Takahashi; Yasuo Kunitomo; Misako Nagasaka; Yoshinobu Kanda; Kaoru Uchimaru; Tomohiro Morio; Yoshihisa Yamano
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

Review 4.  T cell receptor repertoire analysis in HTLV-1-associated diseases.

Authors:  Annaliese Clauze; Yoshimi Enose-Akahata; Steven Jacobson
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.